Skip to content

Released May 10, 2017, after the close

10-Q filed May 10, 2017, 40 days after period end · 0001390478-17-000036

Q1 2017 · 10-Q
Revenue—
Net Income-$4.60MN/M vs Q1 2016N/M vs Q4 2016
EPS Diluted-$3.63no prior Q1 2016 on fileno prior Q4 2016 on file
Operating Income-$5,088,000N/M
Operating Cash Flow-$3,803,000N/M

What the release said

The release

Same quarter

MetricQ1 2017Q1 2016Q1 2015Q1 2014
Revenue——$2.75M$2.17M
Net Income-$4.60M-$16.49M-$10.54M-$2.54M
EPS Diluted-$3.63—-$0.08-$0.02

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

SELLAS Life Sciences Group, Inc. · CIK 1390478 · Engraved from SEC EDGAR